Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-07-04
2006-07-04
Kunz, Gary (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S300000, C530S326000, C530S329000, C530S350000
Reexamination Certificate
active
07070782
ABSTRACT:
The invention provides a purified prostate-specific membrane antigen.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 4569794 (1986-02-01), Smith et al.
patent: 5153118 (1992-10-01), Wright, Jr. et al.
patent: 5162504 (1992-11-01), Horoszewicz
patent: 5538866 (1996-07-01), Israeli et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5773292 (1998-06-01), Bander
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5852167 (1998-12-01), Kay et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5935818 (1999-08-01), Israeli et al.
patent: 5939258 (1999-08-01), Croce et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6107090 (2000-08-01), Bander
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6136311 (2000-10-01), Bander
patent: 6150508 (2000-11-01), Murphy et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: 6288046 (2001-09-01), Jackson et al.
patent: 6348464 (2002-02-01), Jackson et al.
patent: 6372726 (2002-04-01), Slusher et al.
patent: 6384022 (2002-05-01), Jackson et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6413948 (2002-07-01), Slusher et al.
patent: 6452044 (2002-09-01), Jackson et al.
patent: 6458775 (2002-10-01), Jackson et al.
patent: 6479471 (2002-11-01), Jackson et al.
patent: 6569432 (2003-05-01), Israeli et al.
patent: 6586623 (2003-07-01), Tsukamoto et al.
patent: 6649163 (2003-11-01), Bander
patent: 2001/0044459 (2001-11-01), Jackson et al.
patent: 2002/0013295 (2002-01-01), Slusher et al.
patent: 2002/0015704 (2002-02-01), Bander
patent: 2002/0019430 (2002-02-01), Jackson et al.
patent: 2002/0151503 (2002-10-01), Slusher et al.
patent: 2003/0003101 (2003-01-01), Bander
patent: 2003/0007974 (2003-01-01), Nanus et al.
patent: 2003/0017965 (2003-01-01), Slusher et al.
patent: 2003/0031673 (2003-02-01), Bander
patent: 2003/0064912 (2003-04-01), Slusher et al.
patent: 2003/0083374 (2003-05-01), Jackson et al.
patent: 2003/0105088 (2003-06-01), Tsukamoto et al.
patent: 2003/0216468 (2003-11-01), Tsukamoto et al.
patent: 2004/0001846 (2004-01-01), Israeli et al.
patent: 2004/0024188 (2004-02-01), Murphy et al.
patent: 0173951 (1986-12-01), None
patent: WO9409820 (1994-05-01), None
patent: 599626272 (1996-08-01), None
patent: WO9735616 (1997-10-01), None
patent: WO9947554 (1999-09-01), None
patent: 4402096460 (2002-12-01), None
patent: 4502098897 (2002-12-01), None
Feng et al. Proc. Amer. Assoc. Cancer Research 32:239 1991.
Garcia et al.J. Bacteriology, vol. 173, pp. 2093-2098, 1991.
Bell et al.Nucleic Acids Research, vol. 14, pp. 5561-5562, 1986.
Hartnett et al.,J. Bacteriology, vol. 172, pp. 956-966, 1990.
Abdel-Nabi, H. et al. (1992) “Monoclonal Antibodies and Radioimmunoconjugates in the Diagnosis and Treatment of Prostate Cancer”,Seminars in Urology127: 45-54.
Axelrod, H.R., et al. (1968) “Preclinical results and human immunohistochemical studies with90Y-CYT-356. A new prostate cancer therapeutic agent”. Abstract 596. AUA 87thAnnucal Meeting, May. 10-14, 1992. Washington, D.C. (1968).
Carter, B.H. and Coffey, D.S. (1990) “The Prostate: An Increasing Medical Problem”The Prostate16:39-48.
Feng, Q., et al. (1991) “Purification and Biochemical Characetization of the 7E11-C5 Prostate Carcinoma-Associated Antigen”,Proceedings of the American Association for Cancer Research32:239.
Chang, Chawnshang, et al. (1988) “Structural Analysis of Complementary DNA and Amino Acid Sequences of Human and Rat Androgen Receptors”, Proc. Natl Acad. Sci USA 85:7211-7215.
Culver, K.W. et al. (1992) “In Vivo Gene Transfer with Retoviral Vector-Producer Cells for Treatment of Experimental Brain Tumors”, Science 256:1150-1552.
Decensi A, et al (1991) “Phase II Study of the Pure Non-Steroidal Antiandrogen Nilutamde in Prostatic Cancer”, Eur J Cancer 27:1100-1104.
Faber, P.W. et al. (1991) “Characterization of the Human Androgen Transcription Unit” The Journal of Biological Chemistry 266:10743-10749.
Fey, Martin F. et al. (1991) “The Polymerase Chain Reaction: A New Tool for the Detection of Minimal Residual Disease in Haematological Malignancies” Eur J Cancer 27:89-94.
Henttu, Pirkko and Pirkki (1989) “cDNA Coding for the Entire Human Prostate Specific Antigen Shows High Homologies to the Human Tissue Kallikrein Genes”Biochemical and Biophysical Research Communications160:903-910.
Horoszewicz, Julius S. et al. (1987) “Monoclonal Antibodies to a New Antigen Marker in Epithelial Prostatic Cells and Serum of Prostatic Cancer Patients”AntiCancer Research7:927-936.
Huber, Brian E. et al. (1991) “Retroviral-mediated Gene Therapy for the Treatment of Hepatocellular Carcinoma: An Innovative Approach for Cancer Therapy”Proc. Natl. Acad. Sci. USA88:8039-8043.
Israeli, Ron S., et al. (1994) “Expression of the Prostate Specific Membrane Antigen”Cancer Research54:1807-1811.
Israeli, Ron S. et al. (1994) “Sensitive Nested Reverse Transcription Polymerase Chain Reaction Detection of Circulating Prostatic Tumor Cells: Comparison of Prostate-specific Membrane Antigen and Prostate-specific Antigen-based Assays” Cancer Research 54:6306-6310.
Keer, Harold N., et al. (1990) “Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed In Vitro and In Vivo”Journal of Urology143:381385.
Lopes, A. Dwight., et al (1993) “Immonohistochemical and Pharmacokinetic Characterization of the Site-specific Immunocnjugate CYT-356 Derived from Antiprostate Monoclonal Antibody”Cancer Research50: 6423-6429.
Lubahn, Dennis B., et al. (1989) “Sequence of the Intron/exon junctions of the Coding Region of the Human Adrogen Receptor Gene and Identification of a Point Mutation in a family with Complete Androgen Insensitivity”Proc. Natl. Acad. Sci. USA86:9534-9538.
Lundwall, Ake and Lilja, Hans., (1987) “Molecular Cloning of Human Prostate Specific Antigen cDNA” 214, No. 2:317-322.
Mukhopadhyay, Tapas., et al. (1991) “Specific Inhibition of K-ras Expression and Tumorigenicity of Lung Cancer Cells by Antisense RNA1” Cancer Research51:1744-1748.
Riegman, P.H.J., et al. (1989) “The Prostate-Specific Antigen Gene and the Human Glandular Kallikrein-1 Gene are Tandemly Located on Chromosone 19” vol. 247:123-126.
Solin, Timo., (1990) “Gene Expression and Prostate Specificity of Human Prostatic Acid Phosphatase (PAP): Evaluation By RNA Blot Analuses”Biochemica et Biophysica Acta1048:72-77.
Troyer, Abstract C38(1994).
Su, S.L., et al. (1994) “Sensitive Detection of Prostatic Hematogenous Micrometastases Using Prostate Specific Antigen (PSA) and Prostate Specific Membrane Antigen (PSM) Derived parimeters in the Polymerase Chain Reaction”Proceedings of the American Association for Cancer Research35:271.
Vihko, Pirkko., et al (1988) “Molecular Cloning and Sequence Analysis of cDNA Encoding Human Prostatic Acid Phosphatase” 236:275-281.
Vile, Richard G. and Ian R. Hart., (1993) “In Vitro and In Vivo Targeting of Gene Expression to Melanoma Cells”Cancer Research53:962-967.
Israeli, Ron S., et al. (1993) “Molecular Cloning of a Complementary DNA Encoding a Prostate-specific Membrane Antigen”Cancer Research53:227-230.
Waibel, R., et al. (1990) “Therapy of Small Cell Lung Cancer Xenografts in a Nude Mouse model: Evaluation of Radioimmunotherapy and Immonotoxin Therapyogy” 34:54.
Watt, Kenneth W.K., et al (1986) “Human Prostate
Fair William R.
Heston Warren D. W.
Israeli Ron S.
Cooper & Dunham LLP
Gucker Stephen
Kunz Gary
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Prostate-specific membrane antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate-specific membrane antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate-specific membrane antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3609420